• Je něco špatně v tomto záznamu ?

Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells

J Prochazkova, J Fric, K Pokorna, A Neuwirth, M Krulova, A Zajicova, V Holan

. 2009 ; 128 (1 Suppl) : e670-e678.

Jazyk angličtina Země Velká Británie

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12008627
E-zdroje

NLK Free Medical Journals od 1958 do Před 1 rokem
PubMed Central od 1958 do 2021
Medline Complete (EBSCOhost) od 1958-01-01 do Před 1 rokem
Wiley Online Library (archiv) od 1996-01-01 do 2012-12-31
Wiley Free Content od 1996 do Před 1 rokem

The development and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) are strictly regulated by cytokines. Here we show that transforming growth factor-beta (TGF-beta) and interleukin-4 (IL-4) play a crucial and antagonistic role in the development of Tregs. Additionally, these cytokines also have distinct effects on the maintenance of natural (nTregs) and antigen-induced (iTregs) Tregs. Using double-staining and tracking of proliferation of purified and carboxyflourescein succinimidyl ester (CFSE)-labelled mouse T-cell subpopulations we demonstrated that CD4(+) CD25(+) Foxp3(+) iTregs develop upon alloantigenic stimulation in the presence of TGF-beta exclusively from CD4(+) CD25(-) Foxp3(-) precursors. Both the induction of Foxp3 expression and Treg proliferation were prevented when the cells were stimulated in the presence of IL-4. By contrast, nTregs did not proliferate in the presence of the antigen and TGF-beta, and partially lost their Foxp3 expression. IL-4 not only prevented the development of iTregs, but also down-regulated the level of Foxp3 mRNA and decreased the number of Foxp3(+) cells in a population of iTregs. Further analyses proved that IL-4 decreased the expression of Foxp3 only in a population of iTregs, whereas it substantially supported the survival of nTregs. Functional experiments showed that Tregs induced in the presence of alloantigen and TGF-beta inhibited, on a per-cell basis, cell proliferation comparably to nTregs, and their suppressive capacity was not modulated by IL-4. These data suggest that TGF-beta and IL-4 differentially regulate the development of Tregs and distinctly sustain Foxp3 expression and the number of nTregs and iTregs, but have no influence on the suppressive activity of Tregs on a per-cell basis.

000      
04086naa a2200565 a 4500
001      
bmc12008627
003      
CZ-PrNML
005      
20141107090246.0
008      
120316s2009 xxk eng||
009      
AR
040    __
$a ABA008 $b cze $d ABA008
041    0_
$a eng
044    __
$a xxk
100    1_
$a Procházková, Jana $u Institute of Molecular Genetics, Academy of Sciences, Videnska, Prague, Czech Republic. $7 _AN080449
245    10
$a Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells / $c J Prochazkova, J Fric, K Pokorna, A Neuwirth, M Krulova, A Zajicova, V Holan
520    9_
$a The development and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) are strictly regulated by cytokines. Here we show that transforming growth factor-beta (TGF-beta) and interleukin-4 (IL-4) play a crucial and antagonistic role in the development of Tregs. Additionally, these cytokines also have distinct effects on the maintenance of natural (nTregs) and antigen-induced (iTregs) Tregs. Using double-staining and tracking of proliferation of purified and carboxyflourescein succinimidyl ester (CFSE)-labelled mouse T-cell subpopulations we demonstrated that CD4(+) CD25(+) Foxp3(+) iTregs develop upon alloantigenic stimulation in the presence of TGF-beta exclusively from CD4(+) CD25(-) Foxp3(-) precursors. Both the induction of Foxp3 expression and Treg proliferation were prevented when the cells were stimulated in the presence of IL-4. By contrast, nTregs did not proliferate in the presence of the antigen and TGF-beta, and partially lost their Foxp3 expression. IL-4 not only prevented the development of iTregs, but also down-regulated the level of Foxp3 mRNA and decreased the number of Foxp3(+) cells in a population of iTregs. Further analyses proved that IL-4 decreased the expression of Foxp3 only in a population of iTregs, whereas it substantially supported the survival of nTregs. Functional experiments showed that Tregs induced in the presence of alloantigen and TGF-beta inhibited, on a per-cell basis, cell proliferation comparably to nTregs, and their suppressive capacity was not modulated by IL-4. These data suggest that TGF-beta and IL-4 differentially regulate the development of Tregs and distinctly sustain Foxp3 expression and the number of nTregs and iTregs, but have no influence on the suppressive activity of Tregs on a per-cell basis.
590    __
$a bohemika - dle Pubmed
650    02
$a zvířata $7 D000818
650    02
$a CD4-pozitivní T-lymfocyty $x imunologie $x metabolismus $x účinky léků $7 D015496
650    02
$a buněčná diferenciace $x imunologie $x účinky léků $7 D002454
650    02
$a ženské pohlaví $7 D005260
650    02
$a forkhead transkripční faktory $x antagonisté a inhibitory $x biosyntéza $7 D051858
650    02
$a interleukin-4 $x farmakologie $x fyziologie $7 D015847
650    02
$a mužské pohlaví $7 D008297
650    02
$a myši $7 D051379
650    02
$a myši inbrední BALB C $7 D008807
650    02
$a myši inbrední C57BL $7 D008810
650    02
$a messenger RNA $x imunologie $x metabolismus $7 D012333
650    02
$a T-lymfocyty - podskupiny $x imunologie $x účinky léků $7 D016176
650    02
$a T-lymfocyty - podskupiny $x imunologie $x metabolismus $x účinky léků $7 D016176
650    02
$a transformující růstový faktor beta $x farmakologie $x fyziologie $7 D016212
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Frič, Jan $7 xx0106155
700    1_
$a Pokorná, Kateřina $7 xx0140490
700    1_
$a Neuwirth, Aleš $7 xx0108965
700    1_
$a Krulová, Magdaléna $7 xx0083610
700    1_
$a Zajícová, Alena $7 xx0105272
700    1_
$a Holáň, Vladimír, $d 1950- $7 nlk20050169384
773    0_
$t Immunology $p Immunology $g Roč. 128, č. 1 Suppl (2009), s. e670-e678 $w MED00009850 $x 0172-6390
773    0_
$p Immunology $g 128(1 Suppl):e670-8, 2009 Sep
910    __
$a ABA008 $b x $y 4 $z 0
990    __
$a 20120319124554 $b ABA008
991    __
$a 20141107090256 $b ABA008
999    __
$a ok $b bmc $g 901974 $s 765522
BAS    __
$a 3
BMC    __
$a 2009 $b 128 $c 1 Suppl $d e670-e678 $m Immunology $x MED00009850
LZP    __
$a 2012-1Q10/

Najít záznam